in this issue
World News and Views :: Top of the News
Cambrex Acquires Majority Stake in Indian Firm
10:04 PM MDT | November 2, 2010 | Deepti Ramesh
Cambrex (East Rutherford, NJ) says it has acquired a 51% stake in Zenara Pharma (Hyderabad, India), a pharmaceutical company focused on the formulation of final dosage form products, for $20 million. The company will be renamed Cambrex Zenara. Cambrex will acquire the remaining 49% stake in Zenara in early 2016, pursuant to the stock purchase agreement. The acquisition positions Cambrex as one of the leading global suppliers to the large and growing nicotine replacement therapy (NRT) market providing both active pharmaceutical ingredients (APIs) and finished...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee